A brain CP angle contrast MRI is an imaging scan of the cerebellopontine angle—the space between the cerebellum and pons—performed after intravenous gadolinium. It enhances and detects masses (e.g., vestibular schwannoma, meningioma), cysts or inflammation, shows cranial nerve involvement, and defines lesion size, location and relation to the brainstem and internal auditory canal to guide diagnosis and treatment planning.

A brain MRI with contrast highlights areas where the blood–brain barrier is disrupted, improving detection and characterization of tumors, metastases, abscesses, active inflammation (e.g., demyelinating lesions), infections, and vascular abnormalities (aneurysms, arteriovenous malformations). Contrast enhancement helps define lesion size, location, borders, vascularity, and active versus chronic disease, guiding diagnosis, staging, treatment planning, and follow-up.

The CP angle (cerebellopontine angle) is a triangular space between the cerebellum and pons at the lateral brainstem. It contains cranial nerves VII and VIII and nearby vessels. It’s a common site for tumors like vestibular schwannomas and meningiomas, which can cause hearing loss, tinnitus, facial numbness or weakness, and imbalance. Diagnosis is usually by MRI; treatment depends on size and symptoms.

The CP angle test refers to clinical and imaging evaluation for lesions in the cerebellopontine angle. It combines hearing assessment (tuning‑fork tests, pure‑tone audiometry), vestibular and cranial‑nerve examination, and definitive neuroimaging—contrast MRI—to detect tumours (e.g., vestibular schwannoma), cysts or vascular lesions. It’s done for unilateral sensorineural hearing loss, tinnitus, facial numbness/weakness or unexplained balance problems.

A CP (cerebellopontine) angle tumor is a growth at the junction between the cerebellum and pons, commonly vestibular schwannomas or meningiomas. They cause hearing loss, tinnitus, balance problems, facial numbness or weakness, and headaches. Diagnosis relies on MRI; management includes observation, microsurgery, or stereotactic radiosurgery depending on size, symptoms, and patient factors.

Contrast (gadolinium) in a brain MRI improves visualization of lesions by highlighting areas where the blood–brain barrier is disrupted. It helps detect and characterize tumors, infections, inflammation, active multiple sclerosis lesions, and vascular abnormalities, and distinguishes scar from active disease. It’s usually safe, but clinicians check kidney function and allergy history before giving contrast.